Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Adhesion barrier" patented technology

An adhesion barrier is a medical implant that can be used to reduce abnormal internal scarring (adhesions) following surgery by separating the internal tissues and organs while they heal. Surgeons have realized that proper surgical technique is crucial to reduce adhesion formation. In addition, for more than a century, adjuvants including drugs and materials such as animal membranes, gold foil, mineral oil, sheets made of rubber and Teflon, have been used to reduce the risk of adhesion formation. Nevertheless, adhesions do occur and appear to be, to some degree, an almost unavoidable consequence of abdominal and pelvic surgery. Adhesions can lead to significant post-surgical morbidity, bowel obstruction, infertility, and chronic pelvic pain or chronic abdominal pain.

Bioresorbable 3D printed adhesion barriers

An adhesion barrier is comprised of, consists of, or consists essentially of a sheet having a top surface and a bottom surface. The sheet includes either (i) interconnected links or (ii) interconnected, vertically aligned, partitions. The links form pores or the partitions form pores, with the pores extending from the top surface through the bottom surface. The sheet is comprised of, consists of, or consists essentially of a flexible or elastic polymer.
Owner:CARBON INC

Implantable prosthesis

An implantable prosthesis for preventing, reinforcing and / or mending an anatomical defect, including a parastomal hernia which may occur following the formation of a stoma or ostomy opening, such as formed in conjunction with an ileostomy or colostomy. The prosthesis may include a body of biocompatible material having a preformed three-dimensional channel configured to receive a portion of a lateralized bowel formed in conjunction with a parastomal hernia repair or ostomy creation. An adhesion resistant barrier may be located on an inner side of the channel to isolate the portion of the lateralized bowel from a tissue infiltratable surface of the body to reduce or eliminate potential adhesions between the body and the lateralized bowel. A portion of the channel may include a flared segment extending inwardly from the outer periphery to reduce pressure on the portion of the lateralized bowel at the open end of the channel.
Owner:DAVOL INC

A high toughness high-entropy AlCrNbSiTi composite hard coating and a preparation method thereof

PendingCN122446128AAmorphous phaseNanocrystal
The application discloses a high-entropy AlCrNbSiTi composite hard coating with high toughness and a preparation method thereof. The composite hard coating has a gradient layer structure and is composed of an adhesion barrier layer and a tough layer which are sequentially deposited on a substrate by an arc ion plating method. The adhesion barrier layer is a pure Cr layer, and the tough layer is an AlCrNbSiTi layer. The AlCrNbSiTi layer has a composite structure in which nanocrystals and amorphous phases coexist. The AlCrNbSiTi composite hard coating with high hardness, high toughness, excellent high-temperature stability and high film-substrate adhesion can be flexibly designed and prepared according to requirements, so as to meet the required performance of cutting tools, precision molds and wear-resistant parts. The prepared coating has good adhesion and high deposition rate, the performance and production efficiency of the coating are improved, the production cost is reduced, and it is also possible to prepare a relatively thick functional coating.
Owner:SHENZHEN RES INST OF WUHAN UNIVERSITY

High-barrier coating liquid, preparation method thereof and composite material

The invention relates to the technical field of anti-adhesion barrier materials, in particular to a high-barrier coating liquid, a preparation method thereof and a composite material. The high-barrier coating liquid is prepared from the following raw material components in parts by mass: polyvinyl alcohol accounting for 14-29% of the total mass; polyethylene glycol accounts for 0.5-1.5% of the total mass; the acidic functionalized ionic liquid accounts for 0.05-0.15% of the total mass; fumed silica accounts for 30-40% of the total mass; the surfactant accounts for 0.01 to 0.03 percent of the total mass; the cross-linking agent accounts for 0.01-0.03% of the total mass; the defoaming agent accounts for 0.001 to 0.003 percent of the total mass; and the balance of water. The high-barrier coating liquid provided by the invention contains a double-polymer network composed of polyvinyl alcohol-cross-linking agent and polyethylene glycol, the barrier property is improved on the premise of not influencing the transparency of a film, and the high-barrier coating composite material has the properties of high barrier, high transparency and steaming and boiling resistance.
Owner:NANJING HUJIANG COMPOSITE MATERIALS

Dispersion comprising acellular dermal matrix microparticles, membrane comprising same and use thereof

The present invention relates to a dispersion comprising acellular dermal matrix microparticles, a membrane comprising the same, and uses thereof. More specifically, the present invention relates to a membrane comprising a dispersion containing acellular dermal matrix microparticles obtained by supercritical fluid extraction and high pressure dispersion operations, and a method for preparing the same. The acellular dermal membrane according to the present invention exhibits excellent biological stability and biocompatibility, and shows significantly better preservation of extracellular matrix components such as collagen. In addition, the material has excellent mechanical properties, so that the material is easily applied to transplantation operation and suture, and has a porous structure, so that body fluid flow is facilitated, and tissue regeneration can be supported. Thus, the acellular dermal membrane can be applied as wound dressing, adhesion barrier and implantable biomaterials such as drug delivery grafts and artificial skin in the field of regenerative medicine.
Owner:TOTO CO LTD